Therefore, we imagine that targeting KCs, screening new candidate molecules that are specifically and highly expressed in the skin and are closely related to psoriasis, may have been related to these immune cells to influence pathogenesis and development of psoriasis and will have a broad prospect of the treatment exploitation of this disease. This evidence concerns the gene TBCE and psoriasis.